Skip to Content

Join the 'Glaucoma (Open Angle)' group to help and get support from people like you.

Glaucoma (Open Angle) News

25 Million Americans Will Struggle With Vision Problems by 2050

Posted 5 days ago by Drugs.com

THURSDAY, May 19, 2016 – As baby boomers age, the number of Americans with vision problems and blindness is expected to double over the next three decades, a new study suggests. In 2015, slightly more than 12 million Americans had a vision problem. But by 2050, that number will rise to 25 million, the researchers predicted. "This study gives us a GPS for our nation's future eye health," said lead researcher Dr. Rohit Varma, a professor of ophthalmology at the University of Southern California Keck School of Medicine in Los Angeles. "Our group and others have shown in previous studies that those who suffer from vision loss not only have a decreased quality of life but can also experience both physical and mental health decline, including an increased risk for chronic health conditions such as diabetes, depression and even death," he said. The economic burden from vision loss and eye ... Read more

Related support groups: Glaucoma, Cataract, Glaucoma (Open Angle), Macular Degeneration, Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Glaucoma with Pupillary Block, Aphakia, Pseudophakia

Health Tip: Putting Medicine in Your Eyes

Posted 16 Feb 2016 by Drugs.com

-- You may be wary about applying those new eyedrops prescribed by your doctor. The Cleveland Clinic recommends: Use warm water and soap to wash your hands, then dry with a clean towel. Either grab a mirror or lie down before applying the medicine. Look up at the ceiling, then use one hand to pull down the lower eyelid. Hold the medicine in your other hand, resting on your forehead if needed. Without letting the tip of the bottle or tube touch the eye, gently place the medicine inside your lower eyelid. Then close your eye. If you are taking both an ointment and an eye drop, put the eye drop in first. Wait about five minutes before applying the ointment. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Glaucoma (Open Angle), Macular Degeneration, Conjunctivitis, Conjunctivitis - Bacterial, Blepharitis, Eye Redness/Itching, Ocular Herpes Simplex, Keratitis, Glaucoma/Intraocular Hypertension, Corneal Ulcer, Corneal Abrasion, Conjunctivitis - Allergic, Seasonal Allergic Conjunctivitis, Blepharoconjunctivitis, Glaucoma (Narrow Angle), Herpes Simplex Dendritic Keratitis, Glaucoma with Pupillary Block

Green, Leafy Vegetables Each Day May Help Keep Glaucoma at Bay

Posted 14 Jan 2016 by Drugs.com

THURSDAY, Jan. 14, 2016 – Eating green leafy vegetables daily may decrease the risk of glaucoma – a serious eye disease – by 20 percent or more over many years, a new study suggests. "We found those consuming the most green leafy vegetables had a 20 to 30 percent lower risk of glaucoma," said study leader Jae Kang. Kang is an assistant professor of medicine at Brigham and Women's Hospital and Harvard Medical School in Boston. Glaucoma is an eye condition that usually develops when fluid increases in the front part of the eye and causes pressure, damaging the optic nerve. It can lead to loss of vision, according to the U.S. National Eye Institute. Although the study found an association between eating more leafy greens and a lower risk of glaucoma, it didn't prove cause-and-effect. Kang's team followed nearly 64,000 participants in the Nurses' Health Study from 1984 through 2012, and ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Scientists Spot Three More Genes Linked to Glaucoma Risk

Posted 11 Jan 2016 by Drugs.com

MONDAY, Jan. 11, 2016 – The discovery of three more genes linked to the most common type of glaucoma could boost efforts to fight the eye disease, researchers report. The three newly identified genes associated with primary open angle glaucoma bring the total number of such genes to 15, according to the study published online Jan. 11 in Nature Genetics. "Just in time for Glaucoma Awareness Month (January), this unprecedented analysis provides the most comprehensive genetic profile of glaucoma to date," Dr. Paul Sieving, director of the U.S. National Eye Institute (NEI), said in an institute news release. "These findings open avenues for the pursuit of new strategies to screen for, prevent and treat glaucoma," he added. Glaucoma is the most common cause of irreversible vision loss, and it affects 60 million people worldwide and about 2.7 million Americans. The disease causes vision loss ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Glaucoma Patients Have False Notions of Pot's Ability to Treat Their Disease: Survey

Posted 23 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 23, 2015 – Glaucoma patients ask for marijuana prescriptions because they have false notions of its effectiveness in treating the eye disease, a new survey has found. And the trend toward legalization of marijuana has lent additional weight to those misconceptions, the results suggested. Recent research has shown that prescription eye drops are much more effective than marijuana in treating glaucoma, an eye disease that afflicts more than 2 million Americans, said survey author Dr. David Belyea. He is director of glaucoma services at the George Washington University School of Medicine & Health Sciences, in Washington, D.C. Eye doctors need to step up their education efforts and make sure that people understand that marijuana is an impractical option, Belyea and colleagues conclude in their report, which is published Dec. 23 in the journal JAMA Ophthalmology. Glaucoma ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Cannabis, Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

Lupin Receives FDA Approval for Generic Lumigan Ophthalmic Solution 0.03%

Posted 23 Feb 2015 by Drugs.com

Mumbai, India and Baltimore, Maryland – February 23, 2015: Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Bimatoprost Ophthalmic Solution, 0.03% from the United States Food and Drugs Administration (FDA) to market a generic version of Allergan Inc.'s Lumigan Ophthalmic Solution, 0.03%. Lupin Pharmaceuticals Inc. (LPI), the company's U.S. subsidiary would commence marketing the product shortly. Lupin's Bimatoprost Ophthalmic Solution, 0.03% is the AT rated generic equivalent of Lumigan Ophthalmic Solution, 0.03% and is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Lupin's Bimatoprost Ophthalmic Solution, 0.03% filing was made from its Indore facility which was audited in January, 2015. Two Lupin facilities, the Lupin Bioresearch Center, Pune (LBC) and its ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Lumigan, Glaucoma/Intraocular Hypertension, Bimatoprost

Study Supports Benefit of Widely Used Glaucoma Drug

Posted 19 Dec 2014 by Drugs.com

THURSDAY, Dec. 18, 2014 – Prostaglandin analogue eye drops – a common form of glaucoma drug – significantly reduce the risk of vision loss in patients with the eye disease, a new study finds. British researchers led by David Garway-Heath, of the Moorfields Eye Hospital and UCL Institute of Ophthalmology in London, tracked outcomes for more than 500 people newly diagnosed with open-angle glaucoma – the most common form of the disease and one of the leading causes of blindness. About 45 million people worldwide have this type of glaucoma, and the number is expected to rise to 53 million by 2020 and 80 million by 2040, according to the researchers. However, they found that the use of latanoprost – a form of prostaglandin analogue eye drops – reduced the risk of vision loss in these patients by more than 50 percent over two years, compared to those who received an inactive placebo. ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Xalatan, Latanoprost

Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients

Posted 23 Apr 2013 by Drugs.com

Basel, April 19, 2013 – Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza Suspension, indicated for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.4 Elevated IOP is the only modifiable risk factor for glaucoma. Glaucoma is a group of eye diseases that lead to progressive damage of the optic nerve5 and can result in gradual, irreversible loss of vision, and eventually blindness, if left untreated.6 Glaucoma affects more than 2.2 million Americans7 and is the second-leading cause of preventable blindness worldwide.8 Simbrinza is a fixed-dose combination medication that offers a wide range of treatment possibilities due to its strong efficacy and ability to decrease elevated IOP by 21- 35%.1,2,3 In addition, it is the only available, fixed-dose combination ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Intraocular Hypertension, Brimonidine, Brinzolamide

Best Glaucoma Treatments Still a Puzzle, Task Force Reports

Posted 18 Feb 2013 by Drugs.com

MONDAY, Feb. 18 – Drugs and surgery can lower the hallmark inner-eye pressure characteristic of glaucoma – the second-leading cause of blindness in the United States. But research still hasn't identified the best ways to prevent significant vision loss and improve patient satisfaction, according to a prominent government medical group. The U.S. Preventive Services Task Force (USPSTF) reviewed dozens of studies and collective reviews on open-angle glaucoma, which accounts for about 90 percent of all cases, concluding there's inadequate evidence to directly compare the effectiveness of medical, surgical or laser treatments. The task force, comprised of 16 independent experts in prevention and evidence-based medicine, also said it couldn't determine whether glaucoma screening for adults without previous vision problems prevents blindness or enhances long-term health. "We know that ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension

U.S. Glaucoma Cases Jump 22 Percent Over Decade: Report

Posted 13 Dec 2012 by Drugs.com

THURSDAY, Dec. 13 – The prevalence of glaucoma in the United States is 22 percent higher than it was 10 years ago, a new report reveals. Researchers from Prevent Blindness America and the U.S. National Eye Institute reported that more than 2.7 million Americans aged 40 and older are affected by this eye disease, which can damage the optic nerve and gradually lead to blindness. Symptoms for glaucoma develop slowly, so the condition is also known as the "sneak thief of sight." The researchers pointed out in a joint news release that more than 50 percent of those who have glaucoma are not even aware of it. To increase awareness and educate people about glaucoma, Prevent Blindness America joined forces with other leading vision and eye health groups to declare January as National Glaucoma Awareness Month. Among the people at greatest risk for glaucoma are those who are older and have a ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

Coffee Might Raise Glaucoma Risk: Study

Posted 4 Oct 2012 by Drugs.com

THURSDAY, Oct. 4 – People who drink at least three cups of coffee a day might be increasing their risk of developing glaucoma, which can lead to vision loss or blindness, according to Harvard University researchers. Specifically, caffeinated coffee appears to be associated with a type of glaucoma called exfoliation glaucoma, which is characterized by tiny fibers peeling from the eye's lens that can cause a pressure build-up, the researchers said. "While caffeinated coffee has several health benefits, drinking three or more cups of caffeinated coffee was found to be associated with increased risk of developing exfoliation glaucoma, particularly among those with a family history of glaucoma," said lead researcher Jae Hee Kang, assistant professor of medicine at the Channing Division of Network Medicine at Brigham and Women's Hospital in Boston. The increased risk was on the order of 66 ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

Statins Tied to Reduced Glaucoma Risk

Posted 2 Oct 2012 by Drugs.com

TUESDAY, Oct. 2 – Researchers may have discovered yet another potential use for the widely used cholesterol-lowering drugs known as statins. In a new study, older people with high cholesterol who had taken statins for two years had an 8 percent reduced risk of developing open-angle glaucoma, the most common form of the eye disease. "That's a big deal," said Dr. Mark Fromer, an ophthalmologist at Lenox Hill Hospital in New York City, and eye surgeon director for the New York Rangers hockey team. "We're talking 3 million people [in the United States] who have glaucoma and half those people don't know it." Fromer was not involved with the study, which appears in the October issue of Ophthalmology. Glaucoma, which often affects people over 60, can lead to blindness. People at higher risk include those with a family member with glaucoma, blacks and older Hispanics, according to the Glaucoma ... Read more

Related support groups: Lipitor, Simvastatin, Crestor, Atorvastatin, Glaucoma, Pravastatin, Zocor, Lovastatin, Glaucoma (Open Angle), Rosuvastatin, Pravachol, Livalo, Red Yeast Rice, Lescol, Lescol XL, Mevacor, Altoprev, Fluvastatin, Pitavastatin, Altocor

Glaucoma Stent Approved

Posted 25 Jun 2012 by Drugs.com

MONDAY, June 25 – An ocular stent that's designed to reduce inner-eye pressure among people with mild or moderate open-angle glaucoma has been approved by the U.S. Food and Drug Administration. The iStent Trabecular Micro-Bypass Stent System is sanctioned for people with the disease who also have a cataract. The stent, along with surgery to remove the cataract, is designed to prevent damage to the optic nerve caused by high pressure inside the eye. Open-angle glaucoma, which causes this buildup of pressure, is among the leading causes of vision loss and blindness, the FDA said in a news release. The iStent is a small titanium tube that's designed to restore the natural draining of fluid from the eye, potentially decreasing intraocular pressure. The device was clinically studied among 239 people. Because the stent was used in cases where cataract surgery also was performed, ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle)

Research Gets Closer to Genetic Roots of Glaucoma

Posted 27 Apr 2012 by Drugs.com

FRIDAY, April 27 – Two genetic variations are linked to a common form of glaucoma, known as primary open-angle glaucoma, according to new research. Glaucoma affects about 2.2 million people in the United States, the U.S. National Eye Institute said in a news release. "Loss of vision from glaucoma, a common cause of blindness worldwide, is due to irreversible damage to the optic nerve," noted one expert, Dr. Mark Fromer, an ophthalmologist at Lenox Hill Hospital in New York City. "Glaucoma is usually associated with high eye pressure leading to optic nerve damage. There is also a form of glaucoma with normal pressure." In the new study, Janey Wiggs, of Harvard Medical School and Massachusetts Eye and Ear Infirmary in Boston, and colleagues analyzed the DNA sequences of more than 6,000 people. Half of them had primary open-angle glaucoma. This form of the disease is typically associated ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle)

Glaucoma Need Not Steal Sight, Experts Say

Posted 20 Apr 2012 by Drugs.com

FRIDAY, April 20 – Though glaucoma has been nicknamed the silent thief of sight, eye experts now say it generally doesn't have to be that way. "For most people, if you treat early, you should have vision for a lifetime," said Dr. Mark Fromer, an ophthalmologist at Lenox Hill Hospital and medical director of the Fromer Eye Centers, both in New York City, and the eye surgeon director for the New York Rangers hockey team. Glaucoma isn't just one disease but a group of conditions that cause damage to the optic nerve, which connects the eye to the brain. Left untreated, glaucoma can in fact cause blindness. And because the disease can progress for long periods undetected, experts stress that checkups and early detection are key to maintaining vision. Most forms of glaucoma develop because of increased pressure in the eye, according to the Glaucoma Foundation. High eye pressure, also known ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle)

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Glaucoma

Related Drug Support Groups

Lumigan, Xalatan, Travatan, latanoprost, Alphagan, Travatan Z, Azopt, Cosopt, dorzolamide, view more... brimonidine, Alphagan P, Zioptan, Timoptic, travoprost, bimatoprost, Trusopt, brinzolamide, Rescula, Betagan, levobunolol, Propine, dipivefrin, Betoptic-S, Timoptic Ocudose, Betoptic, Simbrinza, dorzolamide / timolol, Cosopt PF, Pilopine-HS, tafluprost, Epinal, Timoptic-XE, Eppy / N, Epifrin, Glaucon, Betimol, Piloptic-6, Qoliana, Ocupress, AK-Beta, Izba, Betaxon, Betagan C-Cap, Isopto Carpine, Pilocar, Istalol, AK-Pro, OptiPranolol, brimonidine / brinzolamide, levobetaxolol, metipranolol, unoprostone, Adsorbocarpine, Pilagan with C Cap, Akarpine, Piloptic-2, Piloptic-3, Piloptic-1, Pilostat, Ocu-Carpine, Ocusert, Piloptic-1 / 2, Piloptic-4